Could flumazenil reverse neurological deficits in acute cerebral ischemia?
G
G
D'Alessandro
G
G
Corso
E
E
Bottacchi
D000208:Acute Disease; D002545:Brain Ischemia / Q000150:complications / Q000188:drug therapy*; D002341:Carotid Artery Thrombosis / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy; D002343:Carotid Artery, Internal / Q000000981:diagnostic imaging; D002533:Cerebral Angiography; D004359:Drug Therapy, Combination; D004401:Dysarthria / Q000209:etiology; D004992:Ethics, Medical; D005442:Flumazenil / Q000494:pharmacology / Q000627:therapeutic use*; D018755:GABA Agonists / Q000494:pharmacology / Q000627:therapeutic use*; D058785:GABA-A Receptor Agonists; D005990:Glycerol / Q000494:pharmacology / Q000627:therapeutic use; D006439:Hemodynamics; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010291:Paresis / Q000209:etiology; D012008:Recurrence; D015912:Thrombolytic Therapy; D005680:gamma-Aminobutyric Acid / Q000502:physiology
D018755:GABA Agonists; D058785:GABA-A Receptor Agonists; D005442:Flumazenil; D005680:gamma-Aminobutyric Acid; D006493:Heparin; D005990:Glycerol